Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial
Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision label v3.6.4 was added to the study record history. The previous revision label v3.6.3 was removed from the history list.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry v3.6.3 was added to the history, and the previous v3.6.2 entry was removed, indicating an update to the study record.SummaryDifference0.1%

- Check43 days agoChange DetectedA newer revision (v3.6.2) was added to the study record history, and an older revision (v3.6.0) was removed, updating the version history.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status shows the study is no longer seeking participants, reflecting the current enrollment status. The record history updates to Revision: v3.6.0, superseding the prior Revision: v3.5.5 entry.SummaryDifference0.4%

- Check65 days agoChange DetectedThe record history shows a new latest revision tag v3.5.5 was added. The previous v3.5.4 tag was removed.SummaryDifference0.1%

- Check86 days agoChange DetectedA new revision entry v3.5.4 is added to the Record History, and the prior entry v3.5.3 is removed, updating the visible version history to reflect the latest site maintenance release.SummaryDifference0.1%

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.